Hi Satishbh,
Reading between the lines as stated by Dr T.
My take, is that once we have completed the AML Phase 2 trial In Israel, the FDA has said that they will approve the Zantrene for commercial sell to all patients, in the U.S.
That is my take and my opinion only, fingers and toes crossed.
IMHO.
Regards
Rossi70
Ann: Positive Pre-IND Guidance from FDA on Zantrene, page-44
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |